Internal radiation dosimetry is a critical aspect of nuclear medicine, as it enables the estimation of the absorbed dose by patients from radiopharmaceuticals administered for diagnostic or therapeutic purposes. The MIRD Committee, established in 1967, has been instrumental in developing and refining guidelines for internal dosimetry. MIRD-226 is the latest in a series of reports and guidelines published by the committee, aiming to provide a comprehensive framework for internal dosimetry.